This content is machine translated 2nd EORTC St. Gallen Gastrointestinal Cancer Conference 2014 VEGF inhibition in metastatic colorectal cancer. The use of the VEGF inhibitor bevacizumab improves the outcome of patients with metastatic colorectal cancer regardless of the chemotherapy chosen. Recent data suggest that the duration of VEGF inhibition…
View Post 12 min This content is machine translated Neuroendocrine tumors Not as rare as you might think Neuroendocrine tumors (NET) are not that rare. The prevalence of these tumors in the gastrointestinal tract is exceeded only by colon carcinoma. Often NETs are not detected until the late…
View Post 10 min This content is machine translated Medication with proton pump inhibitors What are the opportunities and risks? Proton pump inhibitors (PPIs) are the third most commonly used class of drugs in current clinical practice worldwide after antibiotics and statins (Table 1). These highly potent acid inhibitors effectively cure…
View Post 5 min This content is machine translated Second St. Gallen EORTC Conference Multimodality treatment of advanced rectal cancer. Which drugs are suitable for neoadjuvant radiochemotherapy? If there is a complete clinical response, should we wait or operate? And which patients benefit from adjuvant treatment? These were some of…
View Post 2 min This content is machine translated Abdominal surgeries New generation of surgical robots put into operation Since the robot-assisted technology was introduced at the Hirslanden Clinic in 2005 as a new standard in urology, doctors have already performed over 1000 procedures with the previous robot (“Da…
View Post 8 min This content is machine translated ALPPS A promising innovation in liver surgery ALPPS, a new two-step hepatectomy, proved to be a good alternative to the classical methods of portal vein embolization and portal vein ligation in several small studies. The results show…
View Post 4 min This content is machine translated Helicobacter pylori Eradication for the prevention of gastric cancer? At ASCO-GI in San Francisco, David Graham, MD, of Baylor College of Medicine, gave a presentation on the relationship between Helicobacter pylori and gastric cancer, emphasizing the importance of preventive…
View Post 4 min This content is machine translated Gastric Cancer Targeted therapies in HER2-positive tumors. To what extent does the biological understanding of the disease help define the therapy? This question was discussed at the ASCO-GI in San Francisco with regard to potential treatment options…
View Post 6 min This content is machine translated Interview at ASCO GI on new data from the OPUS study. “We are a good step closer to personalized therapy in mCRC” In the treatment of metastatic colorectal cancer, there were new results on subgroup analyses of the OPUS trial at this year’s ASCO GI in San Francisco. As previously shown in…
View Post 4 min This content is machine translated Metastatic colorectal carcinoma To what extent does aspirin affect survival? More recently, studies have shown that aspirin improves overall survival in subgroups with colorectal cancer, specifically those with PIK3CA mutations. To test whether regular aspirin use is associated with survival…
View Post 4 min This content is machine translated 1st Swiss Symposium Peritoneal Malignancies and HIPEC Enabling individualized treatment At the first Swiss symposium on peritoneal malignancies and HIPEC in St. Gallen, experts spoke on the topics of ovarian cancer and metastatic colorectal cancer. It was about current and…
